Geçgel, AslıÖn, SercanÇiftçi, YelizÖzkan, OğuzcanAçar, Fatma PınarKaraca, Burçak2025-03-202025-03-2020242146-3123https://doi.org/10.4274/balkanmedj.galenos.2024.2024-1-86https://search.trdizin.gov.tr/tr/yayin/detay/1273602https://hdl.handle.net/20.500.14034/2148[No abstract available]eninfo:eu-repo/semantics/openAccessAntineoplastic AgentsFemaleGuillain-Barre SyndromeHumansImidazolesMaleMelanomaMiddle AgedOximesPyridonesPyrimidinonesB Raf kinasedabrafenibfluorodeoxyglucose f 18glutamic acidtrametinibvalineantineoplastic agentdabrafenibdipyroneimidazole derivativeoximepyrimidinone derivativetrametinibadultaxillary lymph node dissectionaxillary lymph node metastasisBRAF genecancer adjuvant therapycancer surgerycase reportclinical articlecongenital nevusdrug withdrawaldysphagiaechographyelectromyographyexcisional biopsyfacial droopfacial nerve paralysisfollow upgene mutationGuillain Barre syndromehistopathologyhumanhuman tissueLetterlimb weaknesslumbar puncturemalemelanomamiddle agedphysical examinationplasmapheresispositron emission tomography-computed tomographyreoperationsentinel lymph node biopsytumor volumedrug therapyfemaleGuillain Barre syndromemelanomaGuillain-Barre Syndrome due to Adjuvant Therapy with Dabrafenib Plus TrametinibLetter10.4274/balkanmedj.galenos.2024.2024-1-864143123132-s2.0-85197986358127360238572561Q1